New User? Sign Up | Sign In

Insider Trading - Crinetics Pharmaceuticals Inc. (CRNX)

Select Time period:

Enter Stock Symbol or Cik: Cik Lookup...

Search By Company or Insider Name:
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
CRNX Insider Trading Transactions for Crinetics Pharmaceuticals Inc.

Common stock purchase or sale:
Transaction
Date
Reported
DateTime
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2020-04-17
Purchase
2020-04-20
08:30 am
Crinetics Pharmaceuticals Inc. CRNX PERCEPTIVE ADVISORS LLC
PERCEPTIVE LIFE SCIENCES MASTER FUND LTD
EDELMAN JOSEPH
10% Owner
1,071,428 $14 $14,999,992 3,659,381
(Indirect)
View
2020-04-15
Sale
2020-04-17
6:38 pm
Crinetics Pharmaceuticals Inc. CRNX Vivo Capital VIII LLC
Vivo Capital Fund VIII L.P.
Vivo Capital Surplus Fund VIII L.P.
10% Owner
330,598 $15.45 $5,106,752 298,625
(Indirect)
View
2020-04-03
Sale
2020-04-07
7:27 pm
Crinetics Pharmaceuticals Inc. CRNX Vivo Capital VIII LLC
Vivo Capital Fund VIII L.P.
Vivo Capital Surplus Fund VIII L.P.
10% Owner
306,115 $13.81 $4,226,833 338,738
(Indirect)
View
2020-03-09
Sale
2020-03-11
5:12 pm
Crinetics Pharmaceuticals Inc. CRNX Vivo Capital VIII LLC
Vivo Capital Fund VIII L.P.
Vivo Capital Surplus Fund VIII L.P.
Vivo Opportunity LLC
Vivo Opportunity Fund L.P.
10% Owner
528 $19.5 $10,296 168,165
(Indirect)
View
2020-02-07
Sale
2020-02-11
8:00 pm
Crinetics Pharmaceuticals Inc. CRNX Vivo Capital VIII LLC
Vivo Capital Fund VIII L.P.
Vivo Capital Surplus Fund VIII L.P.
Vivo Opportunity LLC
Vivo Opportunity Fund L.P.
10% Owner
13,460 $21.66 $291,587 168,298
(Indirect)
View
2020-02-04
Sale
2020-02-06
7:22 pm
Crinetics Pharmaceuticals Inc. CRNX Vivo Capital VIII LLC
Vivo Capital Fund VIII L.P.
Vivo Capital Surplus Fund VIII L.P.
Vivo Opportunity LLC
Vivo Opportunity Fund L.P.
10% Owner
13,460 $22.8 $306,888 178,816
(Indirect)
View
2020-01-29
Sale
2020-01-31
8:00 pm
Crinetics Pharmaceuticals Inc. CRNX Vivo Capital VIII LLC
Vivo Capital Fund VIII L.P.
Vivo Capital Surplus Fund VIII L.P.
Vivo Opportunity LLC
Vivo Opportunity Fund L.P.
10% Owner
26,920 $22.07 $594,164 189,335
(Indirect)
View
2019-12-16
Sale
2019-12-18
6:32 pm
Crinetics Pharmaceuticals Inc. CRNX Fust Matthew K
Director
3,500 $22.5 $78,750 12,536
(Direct)
View
2019-06-21
Sale
2019-06-25
7:03 pm
Crinetics Pharmaceuticals Inc. CRNX 5AM Ventures IV L.P.
5AM Co-Investors IV L.P.
5AM Partners IV LLC
ROCKLAGE SCOTT M
DIEKMAN JOHN D
Schwab Andrew J.
Former 10% holder
250,000 $22.2 $5,550,000 94,489
(Indirect)
View
2019-03-20
Sale
2019-03-25
06:04 am
Crinetics Pharmaceuticals Inc. CRNX Vivo Capital VIII LLC
Vivo Capital Fund VIII L.P.
Vivo Capital Surplus Fund VIII L.P.
Vivo Opportunity LLC
Vivo Opportunity Fund L.P.
10% Owner
417,000 $22.25 $9,278,250 210,373
(Indirect)
View
2019-03-18
Sale
2019-03-20
4:48 pm
Crinetics Pharmaceuticals Inc. CRNX 5AM Ventures IV L.P.
5AM Co-Investors IV L.P.
5AM Partners IV LLC
ROCKLAGE SCOTT M
DIEKMAN JOHN D
Schwab Andrew J.
10% Owner
154,839 $24.25 $3,754,954 104,489
(Indirect)
View
2019-01-22
Sale
2019-01-24
7:01 pm
Crinetics Pharmaceuticals Inc. CRNX 5AM Ventures IV L.P.
5AM Co-Investors IV L.P.
5AM Partners IV LLC
ROCKLAGE SCOTT M
DIEKMAN JOHN D
Schwab Andrew J.
10% Owner
262,153 $21.88 $5,734,597 129,483
(Indirect)
View
2018-07-18
Purchase(A)
2018-08-27
6:12 pm
Crinetics Pharmaceuticals Inc. CRNX PERCEPTIVE ADVISORS LLC
PERCEPTIVE LIFE SCIENCES MASTER FUND LTD
EDELMAN JOSEPH
Director
10% Owner
707,648 $18.87 $13,352,902 2,587,953
(Indirect)
View
2018-07-20
Purchase
2018-07-20
7:02 pm
Crinetics Pharmaceuticals Inc. CRNX 5AM Ventures IV L.P.
5AM Co-Investors IV L.P.
5AM Partners IV LLC
ROCKLAGE SCOTT M
DIEKMAN JOHN D
Schwab Andrew J.
10% Owner
115,000 $17 $1,955,000 139,969
(Indirect)
View
2018-07-20
Purchase
2018-07-20
5:19 pm
Crinetics Pharmaceuticals Inc. CRNX PERCEPTIVE ADVISORS LLC
PERCEPTIVE LIFE SCIENCES MASTER FUND LTD
EDELMAN JOSEPH
Director
10% Owner
400,000 $17 $6,800,000 2,280,305
(Indirect)
View
2018-07-20
Purchase
2018-07-20
4:50 pm
Crinetics Pharmaceuticals Inc. CRNX Vivo Capital VIII LLC
Vivo Capital LLC
Vivo Capital Fund VIII L.P.
Vivo Capital Surplus Fund VIII L.P.
Vivo Opportunity LLC
Vivo Opportunity Fund L.P.
10% Owner
353,180 $18.62 $6,575,421 294,357
(Indirect)
View
2018-07-20
Purchase
2018-07-20
4:06 pm
Crinetics Pharmaceuticals Inc. CRNX Krasner Alan Seth
Chief Medical Officer
2,000 $17 $34,000 2,000
(Direct)
View
(A) Indicate amendment filing.

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2020-04-28
Exercise
2020-04-29
5:01 pm
N/A
N/A
Crinetics Pharmaceuticals Inc. CRNX WIERENGA WENDALL
Director
25,329 $0.73 12,500
(Direct)
View
2020-04-28
Exercise
2020-04-29
5:01 pm
N/A
2025-12-10
Crinetics Pharmaceuticals Inc. CRNX WIERENGA WENDALL
Director
25,329 $0.73 12,500
(Direct)
View
2020-02-24
Option Award
2020-02-26
4:18 pm
N/A
2030-02-23
Crinetics Pharmaceuticals Inc. CRNX Krasner Alan Seth
Chief Medical Officer
45,000 $22.61 45,000
(Direct)
View
2020-02-24
Option Award
2020-02-26
4:15 pm
N/A
2030-02-23
Crinetics Pharmaceuticals Inc. CRNX Wilson Marc
CFO
70,000 $22.61 70,000
(Direct)
View
2020-02-24
Option Award
2020-02-26
4:12 pm
N/A
2030-02-23
Crinetics Pharmaceuticals Inc. CRNX Struthers Richard Scott
CEO
200,000 $22.61 200,000
(Direct)
View
2019-12-16
Exercise
2019-12-18
6:32 pm
N/A
N/A
Crinetics Pharmaceuticals Inc. CRNX Fust Matthew K
Director
3,500 $1.91 12,536
(Direct)
View
2019-12-16
Exercise
2019-12-18
6:32 pm
N/A
2028-03-16
Crinetics Pharmaceuticals Inc. CRNX Fust Matthew K
Director
3,500 $1.91 12,536
(Direct)
View
2019-08-05
Gift
2019-08-07
7:31 pm
N/A
N/A
Crinetics Pharmaceuticals Inc. CRNX Struthers Richard Scott
CEO
1,215,805 $0 172,370
(Direct)
View
2019-08-05
Gift
2019-08-07
7:31 pm
N/A
N/A
Crinetics Pharmaceuticals Inc. CRNX Struthers Richard Scott
CEO
1,215,805 $0 172,370
(Indirect)
View
2019-08-05
Exercise
2019-08-07
7:31 pm
N/A
N/A
Crinetics Pharmaceuticals Inc. CRNX Struthers Richard Scott
CEO
10,000 $1.91 172,370
(Indirect)
View
2019-08-05
Exercise
2019-08-07
7:31 pm
N/A
2028-03-16
Crinetics Pharmaceuticals Inc. CRNX Struthers Richard Scott
CEO
10,000 $1.91 172,370
(Direct)
View
2019-07-15
Option Award
2019-07-16
7:56 pm
N/A
2029-07-14
Crinetics Pharmaceuticals Inc. CRNX Okey Stephanie
Director
25,000 $24.15 25,000
(Direct)
View
2019-06-21
Option Award
2019-06-25
4:10 pm
N/A
2029-06-20
Crinetics Pharmaceuticals Inc. CRNX Nichols Weston
Director
12,500 $23.24 12,500
(Direct)
View
2019-06-21
Option Award
2019-06-25
4:10 pm
N/A
2029-06-20
Crinetics Pharmaceuticals Inc. CRNX Nielsen Jack
Director
12,500 $23.24 12,500
(Direct)
View
2019-06-21
Option Award
2019-06-25
4:09 pm
N/A
2029-06-20
Crinetics Pharmaceuticals Inc. CRNX Fust Matthew K
Director
12,500 $23.24 12,500
(Direct)
View
2019-06-21
Option Award
2019-06-25
4:08 pm
N/A
2029-06-20
Crinetics Pharmaceuticals Inc. CRNX Kaldor Stephen W
Director
12,500 $23.24 12,500
(Direct)
View
2019-06-21
Option Award
2019-06-25
4:07 pm
N/A
2029-06-20
Crinetics Pharmaceuticals Inc. CRNX WIERENGA WENDALL
Director
12,500 $23.24 12,500
(Direct)
View
2019-03-08
Option Award
2019-03-12
6:44 pm
N/A
2029-03-07
Crinetics Pharmaceuticals Inc. CRNX Struthers Richard Scott
CEO
176,250 $25.19 176,250
(Direct)
View
2019-03-08
Option Award
2019-03-12
6:43 pm
N/A
2029-03-07
Crinetics Pharmaceuticals Inc. CRNX Wilson Marc
CFO
56,250 $25.19 56,250
(Direct)
View
2019-03-08
Option Award
2019-03-12
6:42 pm
N/A
2029-03-07
Crinetics Pharmaceuticals Inc. CRNX Krasner Alan Seth
Chief Medical Officer
56,250 $25.19 56,250
(Direct)
View
2019-02-20
Other
2019-02-22
8:06 pm
N/A
N/A
Crinetics Pharmaceuticals Inc. CRNX 5AM Ventures IV L.P.
5AM Co-Investors IV L.P.
5AM Partners IV LLC
ROCKLAGE SCOTT M
DIEKMAN JOHN D
Schwab Andrew J.
10% Owner
451,200 $0 1,723
(Indirect)
View
2019-02-20
Other
2019-02-22
8:06 pm
N/A
N/A
Crinetics Pharmaceuticals Inc. CRNX 5AM Ventures IV L.P.
5AM Co-Investors IV L.P.
5AM Partners IV LLC
ROCKLAGE SCOTT M
DIEKMAN JOHN D
Schwab Andrew J.
10% Owner
18,800 $0 1,723
(Indirect)
View
2019-02-20
Other
2019-02-22
8:06 pm
N/A
N/A
Crinetics Pharmaceuticals Inc. CRNX 5AM Ventures IV L.P.
5AM Co-Investors IV L.P.
5AM Partners IV LLC
ROCKLAGE SCOTT M
DIEKMAN JOHN D
Schwab Andrew J.
10% Owner
4,700 $0 1,723
(Indirect)
View
2019-02-20
Other
2019-02-22
8:06 pm
N/A
N/A
Crinetics Pharmaceuticals Inc. CRNX 5AM Ventures IV L.P.
5AM Co-Investors IV L.P.
5AM Partners IV LLC
ROCKLAGE SCOTT M
DIEKMAN JOHN D
Schwab Andrew J.
10% Owner
4,700 $0 1,723
(Indirect)
View
2019-02-20
Other
2019-02-22
8:06 pm
N/A
N/A
Crinetics Pharmaceuticals Inc. CRNX 5AM Ventures IV L.P.
5AM Co-Investors IV L.P.
5AM Partners IV LLC
ROCKLAGE SCOTT M
DIEKMAN JOHN D
Schwab Andrew J.
10% Owner
940 $0 1,723
(Indirect)
View
2019-02-20
Other
2019-02-22
8:06 pm
N/A
N/A
Crinetics Pharmaceuticals Inc. CRNX 5AM Ventures IV L.P.
5AM Co-Investors IV L.P.
5AM Partners IV LLC
ROCKLAGE SCOTT M
DIEKMAN JOHN D
Schwab Andrew J.
10% Owner
940 $0 1,723
(Indirect)
View
2019-02-20
Other
2019-02-22
8:06 pm
N/A
N/A
Crinetics Pharmaceuticals Inc. CRNX 5AM Ventures IV L.P.
5AM Co-Investors IV L.P.
5AM Partners IV LLC
ROCKLAGE SCOTT M
DIEKMAN JOHN D
Schwab Andrew J.
10% Owner
353 $0 1,723
(Indirect)
View
2019-02-20
Other
2019-02-22
8:06 pm
N/A
N/A
Crinetics Pharmaceuticals Inc. CRNX 5AM Ventures IV L.P.
5AM Co-Investors IV L.P.
5AM Partners IV LLC
ROCKLAGE SCOTT M
DIEKMAN JOHN D
Schwab Andrew J.
10% Owner
587 $0 1,723
(Indirect)
View
2019-02-20
Other
2019-02-22
8:06 pm
N/A
N/A
Crinetics Pharmaceuticals Inc. CRNX 5AM Ventures IV L.P.
5AM Co-Investors IV L.P.
5AM Partners IV LLC
ROCKLAGE SCOTT M
DIEKMAN JOHN D
Schwab Andrew J.
10% Owner
783 $0 1,723
(Indirect)
View
2019-02-20
Other
2019-02-22
8:06 pm
N/A
N/A
Crinetics Pharmaceuticals Inc. CRNX 5AM Ventures IV L.P.
5AM Co-Investors IV L.P.
5AM Partners IV LLC
ROCKLAGE SCOTT M
DIEKMAN JOHN D
Schwab Andrew J.
10% Owner
783 $0 1,723
(Indirect)
View
2019-02-20
Other
2019-02-22
8:06 pm
N/A
N/A
Crinetics Pharmaceuticals Inc. CRNX 5AM Ventures IV L.P.
5AM Co-Investors IV L.P.
5AM Partners IV LLC
ROCKLAGE SCOTT M
DIEKMAN JOHN D
Schwab Andrew J.
10% Owner
783 $0 1,723
(Indirect)
View
2019-02-04
Other
2019-02-06
5:35 pm
N/A
N/A
Crinetics Pharmaceuticals Inc. CRNX Versant Venture Capital V L.P.
Versant Affiliates Fund V L.P.
Versant Ophthalmic Affiliates I L.P.
Versant Venture Capital V (Canada) LP
Versant Ventures V LLC
Versant Ventures V (Canada) L.P.
10% Owner
445,470 $0 0
(Indirect)
View
2019-02-04
Other
2019-02-06
5:35 pm
N/A
N/A
Crinetics Pharmaceuticals Inc. CRNX Versant Venture Capital V L.P.
Versant Affiliates Fund V L.P.
Versant Ophthalmic Affiliates I L.P.
Versant Venture Capital V (Canada) LP
Versant Ventures V LLC
Versant Ventures V (Canada) L.P.
10% Owner
13,387 $0 0
(Indirect)
View
2019-02-04
Other
2019-02-06
5:35 pm
N/A
N/A
Crinetics Pharmaceuticals Inc. CRNX Versant Venture Capital V L.P.
Versant Affiliates Fund V L.P.
Versant Ophthalmic Affiliates I L.P.
Versant Venture Capital V (Canada) LP
Versant Ventures V LLC
Versant Ventures V (Canada) L.P.
10% Owner
14,828 $0 0
(Indirect)
View
2019-02-04
Other
2019-02-06
5:35 pm
N/A
N/A
Crinetics Pharmaceuticals Inc. CRNX Versant Venture Capital V L.P.
Versant Affiliates Fund V L.P.
Versant Ophthalmic Affiliates I L.P.
Versant Venture Capital V (Canada) LP
Versant Ventures V LLC
Versant Ventures V (Canada) L.P.
10% Owner
33,903 $0 0
(Indirect)
View
2019-02-04
Other
2019-02-06
5:35 pm
N/A
N/A
Crinetics Pharmaceuticals Inc. CRNX Versant Venture Capital V L.P.
Versant Affiliates Fund V L.P.
Versant Ophthalmic Affiliates I L.P.
Versant Venture Capital V (Canada) LP
Versant Ventures V LLC
Versant Ventures V (Canada) L.P.
10% Owner
9,473 $0 0
(Indirect)
View
2019-02-04
Other
2019-02-06
5:35 pm
N/A
N/A
Crinetics Pharmaceuticals Inc. CRNX Versant Venture Capital V L.P.
Versant Affiliates Fund V L.P.
Versant Ophthalmic Affiliates I L.P.
Versant Venture Capital V (Canada) LP
Versant Ventures V LLC
Versant Ventures V (Canada) L.P.
10% Owner
9,473 $0 0
(Indirect)
View
2019-02-04
Other
2019-02-06
5:35 pm
N/A
N/A
Crinetics Pharmaceuticals Inc. CRNX Versant Venture Capital V L.P.
Versant Affiliates Fund V L.P.
Versant Ophthalmic Affiliates I L.P.
Versant Venture Capital V (Canada) LP
Versant Ventures V LLC
Versant Ventures V (Canada) L.P.
10% Owner
678 $0 0
(Indirect)
View
2019-02-04
Other
2019-02-06
5:35 pm
N/A
N/A
Crinetics Pharmaceuticals Inc. CRNX Versant Venture Capital V L.P.
Versant Affiliates Fund V L.P.
Versant Ophthalmic Affiliates I L.P.
Versant Venture Capital V (Canada) LP
Versant Ventures V LLC
Versant Ventures V (Canada) L.P.
10% Owner
678 $0 0
(Indirect)
View
2018-07-18
Conversion
2018-08-27
6:12 pm
N/A
N/A
Crinetics Pharmaceuticals Inc. CRNX PERCEPTIVE ADVISORS LLC
PERCEPTIVE LIFE SCIENCES MASTER FUND LTD
EDELMAN JOSEPH
Director
10% Owner
1,880,305 $0 2,587,953
(Indirect)
View
2018-07-18
Conversion
2018-08-27
6:12 pm
N/A
N/A
Crinetics Pharmaceuticals Inc. CRNX PERCEPTIVE ADVISORS LLC
PERCEPTIVE LIFE SCIENCES MASTER FUND LTD
EDELMAN JOSEPH
Director
10% Owner
6,186,205 $0 2,587,953
(Indirect)
View
2018-07-20
Conversion
2018-07-20
7:02 pm
N/A
N/A
Crinetics Pharmaceuticals Inc. CRNX 5AM Ventures IV L.P.
5AM Co-Investors IV L.P.
5AM Partners IV LLC
ROCKLAGE SCOTT M
DIEKMAN JOHN D
Schwab Andrew J.
10% Owner
2,797,635 $0 139,969
(Indirect)
View
2018-07-20
Conversion
2018-07-20
7:02 pm
N/A
N/A
Crinetics Pharmaceuticals Inc. CRNX 5AM Ventures IV L.P.
5AM Co-Investors IV L.P.
5AM Partners IV LLC
ROCKLAGE SCOTT M
DIEKMAN JOHN D
Schwab Andrew J.
10% Owner
451,274 $0 139,969
(Indirect)
View
2018-07-20
Conversion
2018-07-20
7:02 pm
N/A
N/A
Crinetics Pharmaceuticals Inc. CRNX 5AM Ventures IV L.P.
5AM Co-Investors IV L.P.
5AM Partners IV LLC
ROCKLAGE SCOTT M
DIEKMAN JOHN D
Schwab Andrew J.
10% Owner
116,567 $0 139,969
(Indirect)
View
2018-07-20
Conversion
2018-07-20
7:02 pm
N/A
N/A
Crinetics Pharmaceuticals Inc. CRNX 5AM Ventures IV L.P.
5AM Co-Investors IV L.P.
5AM Partners IV LLC
ROCKLAGE SCOTT M
DIEKMAN JOHN D
Schwab Andrew J.
10% Owner
18,802 $0 139,969
(Indirect)
View
2018-07-20
Conversion
2018-07-20
7:02 pm
N/A
N/A
Crinetics Pharmaceuticals Inc. CRNX 5AM Ventures IV L.P.
5AM Co-Investors IV L.P.
5AM Partners IV LLC
ROCKLAGE SCOTT M
DIEKMAN JOHN D
Schwab Andrew J.
10% Owner
9,204,220 $0 139,969
(Indirect)
View
2018-07-20
Conversion
2018-07-20
7:02 pm
N/A
N/A
Crinetics Pharmaceuticals Inc. CRNX 5AM Ventures IV L.P.
5AM Co-Investors IV L.P.
5AM Partners IV LLC
ROCKLAGE SCOTT M
DIEKMAN JOHN D
Schwab Andrew J.
10% Owner
1,484,690 $0 139,969
(Indirect)
View
2018-07-20
Conversion
2018-07-20
7:02 pm
N/A
N/A
Crinetics Pharmaceuticals Inc. CRNX 5AM Ventures IV L.P.
5AM Co-Investors IV L.P.
5AM Partners IV LLC
ROCKLAGE SCOTT M
DIEKMAN JOHN D
Schwab Andrew J.
10% Owner
383,507 $0 139,969
(Indirect)
View
2018-07-20
Conversion
2018-07-20
7:02 pm
N/A
N/A
Crinetics Pharmaceuticals Inc. CRNX 5AM Ventures IV L.P.
5AM Co-Investors IV L.P.
5AM Partners IV LLC
ROCKLAGE SCOTT M
DIEKMAN JOHN D
Schwab Andrew J.
10% Owner
61,861 $0 139,969
(Indirect)
View
2018-07-20
Conversion
2018-07-20
5:19 pm
N/A
N/A
Crinetics Pharmaceuticals Inc. CRNX PERCEPTIVE ADVISORS LLC
PERCEPTIVE LIFE SCIENCES MASTER FUND LTD
EDELMAN JOSEPH
Director
10% Owner
1,880,305 $0 2,280,305
(Indirect)
View
2018-07-20
Conversion
2018-07-20
5:19 pm
N/A
N/A
Crinetics Pharmaceuticals Inc. CRNX PERCEPTIVE ADVISORS LLC
PERCEPTIVE LIFE SCIENCES MASTER FUND LTD
EDELMAN JOSEPH
Director
10% Owner
6,186,205 $0 2,280,305
(Indirect)
View
2018-07-20
Conversion
2018-07-20
4:50 pm
N/A
N/A
Crinetics Pharmaceuticals Inc. CRNX Vivo Capital VIII LLC
Vivo Capital LLC
Vivo Capital Fund VIII L.P.
Vivo Capital Surplus Fund VIII L.P.
Vivo Opportunity LLC
Vivo Opportunity Fund L.P.
10% Owner
2,560,613 $0 294,357
(Indirect)
View
2018-07-20
Conversion
2018-07-20
4:50 pm
N/A
N/A
Crinetics Pharmaceuticals Inc. CRNX Vivo Capital VIII LLC
Vivo Capital LLC
Vivo Capital Fund VIII L.P.
Vivo Capital Surplus Fund VIII L.P.
Vivo Opportunity LLC
Vivo Opportunity Fund L.P.
10% Owner
353,590 $0 294,357
(Indirect)
View
2018-07-20
Conversion
2018-07-20
4:50 pm
N/A
N/A
Crinetics Pharmaceuticals Inc. CRNX Vivo Capital VIII LLC
Vivo Capital LLC
Vivo Capital Fund VIII L.P.
Vivo Capital Surplus Fund VIII L.P.
Vivo Opportunity LLC
Vivo Opportunity Fund L.P.
10% Owner
413,040 $0 294,357
(Indirect)
View
2018-07-20
Conversion
2018-07-20
4:50 pm
N/A
N/A
Crinetics Pharmaceuticals Inc. CRNX Vivo Capital VIII LLC
Vivo Capital LLC
Vivo Capital Fund VIII L.P.
Vivo Capital Surplus Fund VIII L.P.
Vivo Opportunity LLC
Vivo Opportunity Fund L.P.
10% Owner
57,035 $0 294,357
(Indirect)
View
2018-07-20
Conversion
2018-07-20
4:50 pm
N/A
N/A
Crinetics Pharmaceuticals Inc. CRNX Vivo Capital VIII LLC
Vivo Capital LLC
Vivo Capital Fund VIII L.P.
Vivo Capital Surplus Fund VIII L.P.
Vivo Opportunity LLC
Vivo Opportunity Fund L.P.
10% Owner
8,424,416 $0 294,357
(Indirect)
View
2018-07-20
Conversion
2018-07-20
4:50 pm
N/A
N/A
Crinetics Pharmaceuticals Inc. CRNX Vivo Capital VIII LLC
Vivo Capital LLC
Vivo Capital Fund VIII L.P.
Vivo Capital Surplus Fund VIII L.P.
Vivo Opportunity LLC
Vivo Opportunity Fund L.P.
10% Owner
1,163,311 $0 294,357
(Indirect)
View
2018-07-20
Conversion
2018-07-20
4:50 pm
N/A
N/A
Crinetics Pharmaceuticals Inc. CRNX Vivo Capital VIII LLC
Vivo Capital LLC
Vivo Capital Fund VIII L.P.
Vivo Capital Surplus Fund VIII L.P.
Vivo Opportunity LLC
Vivo Opportunity Fund L.P.
10% Owner
1,358,903 $0 294,357
(Indirect)
View
2018-07-20
Conversion
2018-07-20
4:50 pm
N/A
N/A
Crinetics Pharmaceuticals Inc. CRNX Vivo Capital VIII LLC
Vivo Capital LLC
Vivo Capital Fund VIII L.P.
Vivo Capital Surplus Fund VIII L.P.
Vivo Opportunity LLC
Vivo Opportunity Fund L.P.
10% Owner
187,648 $0 294,357
(Indirect)
View
2018-07-20
Conversion
2018-07-20
4:34 pm
N/A
N/A
Crinetics Pharmaceuticals Inc. CRNX Versant Venture Capital V L.P.
Versant Affiliates Fund V L.P.
Versant Ophthalmic Affiliates I L.P.
Versant Venture Capital V (Canada) LP
10% Owner
2,557,392 $0 0
(Indirect)
View
2018-07-20
Conversion
2018-07-20
4:34 pm
N/A
N/A
Crinetics Pharmaceuticals Inc. CRNX Versant Venture Capital V L.P.
Versant Affiliates Fund V L.P.
Versant Ophthalmic Affiliates I L.P.
Versant Venture Capital V (Canada) LP
10% Owner
76,927 $0 0
(Indirect)
View
2018-07-20
Conversion
2018-07-20
4:34 pm
N/A
N/A
Crinetics Pharmaceuticals Inc. CRNX Versant Venture Capital V L.P.
Versant Affiliates Fund V L.P.
Versant Ophthalmic Affiliates I L.P.
Versant Venture Capital V (Canada) LP
10% Owner
85,253 $0 0
(Indirect)
View
2018-07-20
Conversion
2018-07-20
4:34 pm
N/A
N/A
Crinetics Pharmaceuticals Inc. CRNX Versant Venture Capital V L.P.
Versant Affiliates Fund V L.P.
Versant Ophthalmic Affiliates I L.P.
Versant Venture Capital V (Canada) LP
10% Owner
194,629 $0 0
(Indirect)
View
2018-07-20
Conversion
2018-07-20
4:34 pm
N/A
N/A
Crinetics Pharmaceuticals Inc. CRNX Versant Venture Capital V L.P.
Versant Affiliates Fund V L.P.
Versant Ophthalmic Affiliates I L.P.
Versant Venture Capital V (Canada) LP
10% Owner
412,534 $0 0
(Indirect)
View
2018-07-20
Conversion
2018-07-20
4:34 pm
N/A
N/A
Crinetics Pharmaceuticals Inc. CRNX Versant Venture Capital V L.P.
Versant Affiliates Fund V L.P.
Versant Ophthalmic Affiliates I L.P.
Versant Venture Capital V (Canada) LP
10% Owner
12,409 $0 0
(Indirect)
View
2018-07-20
Conversion
2018-07-20
4:34 pm
N/A
N/A
Crinetics Pharmaceuticals Inc. CRNX Versant Venture Capital V L.P.
Versant Affiliates Fund V L.P.
Versant Ophthalmic Affiliates I L.P.
Versant Venture Capital V (Canada) LP
10% Owner
13,736 $0 0
(Indirect)
View
2018-07-20
Conversion
2018-07-20
4:34 pm
N/A
N/A
Crinetics Pharmaceuticals Inc. CRNX Versant Venture Capital V L.P.
Versant Affiliates Fund V L.P.
Versant Ophthalmic Affiliates I L.P.
Versant Venture Capital V (Canada) LP
10% Owner
31,396 $0 0
(Indirect)
View
2018-07-20
Conversion
2018-07-20
4:34 pm
N/A
N/A
Crinetics Pharmaceuticals Inc. CRNX Versant Venture Capital V L.P.
Versant Affiliates Fund V L.P.
Versant Ophthalmic Affiliates I L.P.
Versant Venture Capital V (Canada) LP
10% Owner
8,413,817 $0 0
(Indirect)
View
2018-07-20
Conversion
2018-07-20
4:34 pm
N/A
N/A
Crinetics Pharmaceuticals Inc. CRNX Versant Venture Capital V L.P.
Versant Affiliates Fund V L.P.
Versant Ophthalmic Affiliates I L.P.
Versant Venture Capital V (Canada) LP
10% Owner
253,091 $0 0
(Indirect)
View
2018-07-20
Conversion
2018-07-20
4:34 pm
N/A
N/A
Crinetics Pharmaceuticals Inc. CRNX Versant Venture Capital V L.P.
Versant Affiliates Fund V L.P.
Versant Ophthalmic Affiliates I L.P.
Versant Venture Capital V (Canada) LP
10% Owner
280,485 $0 0
(Indirect)
View
2018-07-20
Conversion
2018-07-20
4:34 pm
N/A
N/A
Crinetics Pharmaceuticals Inc. CRNX Versant Venture Capital V L.P.
Versant Affiliates Fund V L.P.
Versant Ophthalmic Affiliates I L.P.
Versant Venture Capital V (Canada) LP
10% Owner
640,332 $0 0
(Indirect)
View
2018-07-20
Conversion
2018-07-20
4:34 pm
N/A
N/A
Crinetics Pharmaceuticals Inc. CRNX Versant Venture Capital V L.P.
Versant Affiliates Fund V L.P.
Versant Ophthalmic Affiliates I L.P.
Versant Venture Capital V (Canada) LP
10% Owner
1,357,240 $0 0
(Indirect)
View
2018-07-20
Conversion
2018-07-20
4:34 pm
N/A
N/A
Crinetics Pharmaceuticals Inc. CRNX Versant Venture Capital V L.P.
Versant Affiliates Fund V L.P.
Versant Ophthalmic Affiliates I L.P.
Versant Venture Capital V (Canada) LP
10% Owner
40,826 $0 0
(Indirect)
View
2018-07-20
Conversion
2018-07-20
4:34 pm
N/A
N/A
Crinetics Pharmaceuticals Inc. CRNX Versant Venture Capital V L.P.
Versant Affiliates Fund V L.P.
Versant Ophthalmic Affiliates I L.P.
Versant Venture Capital V (Canada) LP
10% Owner
45,192 $0 0
(Indirect)
View
2018-07-20
Conversion
2018-07-20
4:34 pm
N/A
N/A
Crinetics Pharmaceuticals Inc. CRNX Versant Venture Capital V L.P.
Versant Affiliates Fund V L.P.
Versant Ophthalmic Affiliates I L.P.
Versant Venture Capital V (Canada) LP
10% Owner
103,293 $0 0
(Indirect)
View